Lifecore Biomedical, Inc. De (LFCR) FCF Margin (2010 - 2025)

Lifecore Biomedical has reported FCF Margin for 16 years, with the latest figure at 1.4% in Q2 2025.

• On a quarterly basis, FCF Margin fell 1725.0% year-over-year to 1.4% in Q2 2025; TTM through May 2025 was 10.9%, a 324.0% increase from a year earlier, with the FY2025 full-year figure at 10.57%, up 357.0% from the prior year.
• FCF Margin was 1.4% for Q2 2025 at Lifecore Biomedical, up from 12.11% in the prior quarter.
• The five-year high for FCF Margin was 15.84% in Q2 2024, with the low at 70.94% in Q1 2023.
• Average FCF Margin over 5 years is 28.64%, with a median of 27.35% recorded in 2024.
• The sharpest annual moves came in 2021 and 2024: FCF Margin slumped 8639 bps in 2021, then jumped 4914 bps in 2024.
• Over 5 years, FCF Margin stood at 39.98% in 2021, then grew by 29 bps to 28.36% in 2022, then jumped by 65 bps to 9.86% in 2023, then tumbled by 167 bps to 26.35% in 2024, then jumped by 95 bps to 1.4% in 2025.
• The last three FCF Margin figures came in at 1.4% (Q2 2025), 12.11% (Q1 2025), and 26.35% (Q4 2024), per Business Quant data.